Sabra Healthcare REIT (NASDAQ:SBRA) Updates FY 2025 Earnings Guidance

Key Points

• Sabra Healthcare REIT updated its FY 2025 earnings guidance, projecting earnings per share between 1.450 and 1.470, slightly below the consensus estimate of 1.461.
• The company's stock traded at $18.41 during midday trading, with a market capitalization of $4.38 billion and a P/E ratio of 31.20.
• Analysts rated the stock with an average rating of "Moderate Buy" and set a target price of $19.67, reflecting confidence in its growth potential.

Sabra Healthcare REIT (NASDAQ:SBRA - Get Free Report) issued an update on its FY 2025 earnings guidance on Monday morning. The company provided earnings per share (EPS) guidance of 1.450-1.470 for the period, compared to the consensus estimate of 1.461. The company issued revenue guidance of -.

Sabra Healthcare REIT Trading Up 0.7%

Shares of SBRA stock traded up $0.14 on Wednesday, reaching $18.32. The company had a trading volume of 1,518,826 shares, compared to its average volume of 2,428,833. The company has a current ratio of 4.22, a quick ratio of 4.22 and a debt-to-equity ratio of 0.89. The stock has a market cap of $4.36 billion, a PE ratio of 24.11, a PEG ratio of 1.53 and a beta of 0.86. The company has a 50-day moving average of $18.18 and a 200-day moving average of $17.52. Sabra Healthcare REIT has a 12 month low of $15.60 and a 12 month high of $20.03.

Sabra Healthcare REIT (NASDAQ:SBRA - Get Free Report) last announced its quarterly earnings results on Monday, August 4th. The real estate investment trust reported $0.38 EPS for the quarter, beating analysts' consensus estimates of $0.36 by $0.02. Sabra Healthcare REIT had a return on equity of 6.68% and a net margin of 24.87%. The company had revenue of $189.15 million during the quarter, compared to analysts' expectations of $185.64 million. During the same period in the prior year, the business posted $0.36 EPS. Sabra Healthcare REIT's revenue was up 7.4% on a year-over-year basis. On average, equities analysts forecast that Sabra Healthcare REIT will post 1.45 earnings per share for the current year.

Sabra Healthcare REIT Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, August 29th. Investors of record on Friday, August 15th will be paid a $0.30 dividend. This represents a $1.20 dividend on an annualized basis and a yield of 6.6%. The ex-dividend date is Friday, August 15th. Sabra Healthcare REIT's dividend payout ratio is 203.39%.

Analyst Upgrades and Downgrades

SBRA has been the topic of several recent research reports. JMP Securities increased their price objective on Sabra Healthcare REIT from $20.00 to $22.00 and gave the stock a "market outperform" rating in a research report on Wednesday. Scotiabank increased their price objective on Sabra Healthcare REIT from $19.00 to $20.00 and gave the stock a "sector perform" rating in a research report on Monday, June 23rd. Three investment analysts have rated the stock with a hold rating, three have given a buy rating and one has assigned a strong buy rating to the company's stock. According to MarketBeat, Sabra Healthcare REIT presently has a consensus rating of "Moderate Buy" and a consensus target price of $20.00.

Insider Buying and Selling

In other news, Director Michael J. Foster sold 11,000 shares of the stock in a transaction dated Tuesday, May 20th. The shares were sold at an average price of $18.22, for a total value of $200,420.00. Following the completion of the transaction, the director owned 64,725 shares of the company's stock, valued at approximately $1,179,289.50. This represents a 14.53% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 1.10% of the stock is currently owned by company insiders.

Institutional Trading of Sabra Healthcare REIT

An institutional investor recently raised its position in Sabra Healthcare REIT stock. Focus Partners Wealth boosted its stake in Sabra Healthcare REIT, Inc. (NASDAQ:SBRA - Free Report) by 11.4% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 23,146 shares of the real estate investment trust's stock after acquiring an additional 2,375 shares during the period. Focus Partners Wealth's holdings in Sabra Healthcare REIT were worth $404,000 at the end of the most recent quarter. 99.40% of the stock is currently owned by institutional investors.

Sabra Healthcare REIT Company Profile

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.